Caprion-HistoGeneX
is now CellCarta

Mapping Precision Medicine

Watch the video

Reveal Biosciences is now part of CellCarta

New generation of AI-Powered Pathology Solutions to enhance research, clinical trials, and improve patient outcomes globally

More details

Reveal Biosciences is now part of CellCarta

Our singular vision
has a bold, new name

Learn More

Mosaic Laboratories is now part of CellCarta

Expanding our histological biomarker franchise to support global clinical trials

More details

Mosaic Laboratories is now part of CellCarta

Clinical Logistics Inc. is now part of CellCarta

Expanding our specimen logistics services to better support global clinical trials

More details

Clinical Logistics Inc. is now part of CellCarta

COVID-19 clinical testing for drug development

Your partner of choice to move your COVID-19 vaccine research forward and ensure business continuity

More details

COVID-19 clinical testing for drug development

Services

Technologies

Therapeutic Areas

Phases

Latest News and Events

News

CellCarta acquires Reveal Biosciences

May 11, 2021

More info

CellCarta

News

Precision Medicine Leader Caprion-HistoGeneX Rebrands as CellCarta

January 26, 2021

More info

News

Caprion-HistoGeneX expands its histological biomarker franchise by joining forces with Mosaic Laboratories

January 12, 2021

More info

News

Caprion-HistoGeneX acquires
Clinical Logistics Inc. - A virtual central specimen management CRO

January 7, 2021

More info

Services

Clinically Relevant Biomarkers in FFPE

Quantify Multiplex Biomarkers in FFPE Tissue Samples using MRM

More info

Clinically Relevant Biomarkers in FFPE

Services

MDSC Assays

Predict responses to immune checkpoint inhibitors and improve patient stratification through MDSC monitoring

More info

Therapeutic Area

Oncology

Developing and deploying assays for exploratory, secondary, and primary endpoints to support multitude of oncology programs.

More info

Therapeutic Area

Infectious Diseases

From vaccine development to identification and validation of clinical biomarkers, CellCarta has the knowledge and technology to support the development of treatments for infectious diseases.

More info

Infectious Diseases

Science Hub

Press Releases

CellCarta acquires Reveal Biosciences

May 11, 2021

Histopathology

More info

Scientific Publications

Microenvironmental regulation of tumour immunity and response to immunotherapy

April 13, 2021

Histopathology

More info

Brochures

CellCarta – Mapping precision Medicine

February 9, 2021

More info

Scientific Publications

Preclinical and clinical biomarker studies of CT1812:
A novel approach to Alzheimer’s disease modification

February 8, 2021

Proteomics/Mass Spectrometry

More info

Careers

The best scientific minds working together to advance precision medicine

If you are passionate about science, join CellCarta and help shape the future of precision medicine.

See our job opportunities

Brandbourg_Caprion-1335-v2